Literature DB >> 23797276

Synergistic effect of inhibitors of fatty acid desaturases on Trypanosoma parasites.

Andrés Alloatti1, Karina E J Tripodi, Antonio D Uttaro.   

Abstract

The pathway for unsaturated fatty acid biosynthesis is essential in trypanosomatid parasites and has been a key target in our work on the discovery and analysis of several inhibitory compounds. Here, we show the effect of novel inhibitors of stearoyl-CoA desaturase (SCD) and oleate desaturase (OD), alone and in combination, on the growth rate of parasite cultures. GS-456332, an inhibitor of human Δ9 desaturase, efficiently inhibited growth of both Trypanosoma cruzi epimastigotes and Trypanosoma brucei bloodstream form cells, with EC50 values of 136.9 ± 24.2 and 9.4 ± 3.1 nM, respectively. This effect was specific for SCD. Stearolic acid (9-octadecynoic acid) was also able to arrest T. cruzi and T. brucei growth by specific inhibition of their OD, with EC50 values of 1.0 ± 0.2 μM and 0.1 ± 0.01 μM, respectively. When these compounds were administered simultaneously, a clearly synergistic effect was observed for both Trypanosoma species, with EC50 values in the low nanomolar range. These results demonstrate the feasibility of using combinations of drugs, inhibiting different enzymes on the same metabolic pathway, for the development of more efficient chemotherapeutic strategies against neglected diseases caused by these parasites.

Entities:  

Year:  2013        PMID: 23797276     DOI: 10.1007/s00436-013-3508-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  23 in total

1.  Highly specific methyl-end fatty-acid desaturases of trypanosomatids.

Authors:  Andrés Alloatti; Antonio D Uttaro
Journal:  Mol Biochem Parasitol       Date:  2010-10-23       Impact factor: 1.759

Review 2.  Stearoyl-CoA desaturase-1: a novel key player in the mechanisms of cell proliferation, programmed cell death and transformation to cancer.

Authors:  R Ariel Igal
Journal:  Carcinogenesis       Date:  2010-07-01       Impact factor: 4.944

3.  A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei.

Authors:  E Wirtz; S Leal; C Ochatt; G A Cross
Journal:  Mol Biochem Parasitol       Date:  1999-03-15       Impact factor: 1.759

4.  Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.

Authors:  C J Canfield; M Pudney; W E Gutteridge
Journal:  Exp Parasitol       Date:  1995-05       Impact factor: 2.011

5.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

6.  New findings of insecticide resistance in Triatoma infestans (Heteroptera: Reduviidae) from the Gran Chaco.

Authors:  M D Germano; G Roca Acevedo; G A Mougabure Cueto; A C Toloza; C V Vassena; M I Picollo
Journal:  J Med Entomol       Date:  2010-11       Impact factor: 2.278

7.  Drug synergy in experimental African trypanosomiasis.

Authors:  J Williamson; J C March; T J Scott-Finnigan
Journal:  Tropenmed Parasitol       Date:  1982-06

8.  Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.

Authors:  C Katlama; S De Wit; E O'Doherty; M Van Glabeke; N Clumeck
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

Review 9.  The trypanosomiases.

Authors:  Michael P Barrett; Richard J S Burchmore; August Stich; Julio O Lazzari; Alberto Carlos Frasch; Juan José Cazzulo; Sanjeev Krishna
Journal:  Lancet       Date:  2003-11-01       Impact factor: 79.321

10.  Novel, potent, selective, and metabolically stable stearoyl-CoA desaturase (SCD) inhibitors.

Authors:  Dmitry O Koltun; Eric Q Parkhill; Natalya I Vasilevich; Andrei I Glushkov; Timur M Zilbershtein; Alexei V Ivanov; Andrew G Cole; Ian Henderson; Nathan A Zautke; Sandra A Brunn; Nevena Mollova; Kwan Leung; Jeffrey W Chisholm; Jeff Zablocki
Journal:  Bioorg Med Chem Lett       Date:  2009-02-08       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.